JPRN-UMIN000010125已完成1 期
Phase 1 trial of Nab-paclitaxel and Gemcitabine for metastatic breast cancer - Phase 1 trial of Nab-paclitaxel and Gemcitabine for metastatic breast cancer
Tokyo-West Tokushukai Hospital0 个研究点目标入组 6 人开始时间: 2013年2月26日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1) Inflammatory and bilateral breast cancer 2) HER2 positive confirmed by IHC or FISH 3) Active another cancer 4) History of hypersensitivity reaction 5) Other severe complications, such as pulmonary emphysema or pulmonary fibrosis, uncontrollable diabetes, heart failure, renal insufficiency, liver failure 6) Neuropathy <= grade1 7) Radiation therapy for chest 8) Serious myelosuppression 9) Infection 10) Pregnant or possibility pregnancy or nursing woman 11) History of hypersensitivity for albumin 12) Physician judged improper to entry this trial
研究者
相似试验
已完成
1 期
Phase I trial of Gemcitabine plus nab-Paclitaxel for metastatic breast cancerBreast cancerJPRN-UMIN000009067Okayama Univesity Hospital9
已完成
不适用
Phase I study of nab-paclitaxel and gemcitabine chemoradiotherapy for borderline resectable and locally advanced unresectable pancreatic ductal adenocarcinomapancreatic cancerJPRN-UMIN000030551Mie university15
进行中（未招募）
1 期
Phase I-II trial of gemcitabine plus nab-paclitaxel (GemBrax) followed by FOLFIRINOX as first-line treatment of patients with metastatic pancreatic adenocarcinoma - GABRINOXEUCTR2012-003678-13-FRInstitut Régional de Cancerologie de Montpellier - Val d’Aurelle118
已完成
不适用
Phase1 trial of weekly paclitaxel and gemcitabine in previously anthracycline-treated patients with locally advanced or metastatic breast cancer (SBCCSG-17)Breast CancerJPRN-UMIN000004084Saitama Breast Cancer Clinical Study Group(SBCCSG)12
已完成
不适用
Phase I/II study of gemcitabine and nab-paclitaxel with radiation therapy in patients with pancreatic cancer.pancreatic cancerJPRN-UMIN000017751Department of Surgery, Keio University School of Medicine30